Literature DB >> 9660106

Cerebrospinal fluid levels of non-neurotransmitter amino acids in patients with Alzheimer's disease.

J A Molina1, F J Jiménez-Jiménez, C Vargas, P Gómez, F de Bustos, M Ortí-Pareja, A Tallón-Barranco, J Benito-León, J Arenas, R Enríquez-de-Salamanca.   

Abstract

We measured the CSF levels of 21 and the plasma levels of 24 amino acids in 37 patients with Alzheimer's disease (AD) and in 32 matched controls. We used an ion-exchange chromatography method. When compared with controls, AD patients had lower CSF levels of phosphoserine, citrulline, alfa-aminobutyric acid, methionine, and ethanolamine; and higher CSF levels of threonine, serine, lysine, histidine and arginine. However, when expressed relative to CSF protein, CSF levels of serine, lysine, histidine, and arginine, were normal. AD patients had higher plasma levels of phosphoserine, threonine, citrulline, hydroxyproline, and proline; and lower plasma levels of alfa-aminobutyric acid, methionine, leucine and ethanolamine. The CSF/plasma ratios of phosphoserine, serine, citrulline, alfa-aminobutyric acid and arginine were significantly lower in AD patients than those of controls. CSF amino acid levels were not related with the duration and severity of the disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9660106     DOI: 10.1007/s007020050057

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  8 in total

1.  "Add-On"-therapy with an individualized preparation consisting of free amino acids for patients with a major depression.

Authors:  Rottraut Ille; Jürgen Spona; Michaela Zickl; Peter Hofmann; Theresa Lahousen; Nina Dittrich; Götz Bertha; Karin Hasiba; Franz Alfons Mahnert; Hans-Peter Kapfhammer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-06       Impact factor: 5.270

2.  Reverting Metabolic Dysfunction in Cortex and Cerebellum of APP/PS1 Mice, a Model for Alzheimer's Disease by Pioglitazone, a Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Agonist.

Authors:  Kai Lun Chang; Ling Rong Wong; Hai Ning Pee; Shili Yang; Paul Chi-Lui Ho
Journal:  Mol Neurobiol       Date:  2019-04-23       Impact factor: 5.590

3.  Lipidomics of Alzheimer's disease: current status.

Authors:  Paul L Wood
Journal:  Alzheimers Res Ther       Date:  2012-02-01       Impact factor: 6.982

4.  Changes in amino acids and nitric oxide concentration in cerebrospinal fluid during labor pain.

Authors:  Rama Sethuraman; Tat-Leang Lee; Jen-Wun Chui; Shinro Tachibana
Journal:  Neurochem Res       Date:  2006-08-29       Impact factor: 4.414

5.  Induction of serine racemase expression and D-serine release from microglia by amyloid beta-peptide.

Authors:  Sheng-Zhou Wu; Angela M Bodles; Mandy M Porter; W Sue T Griffin; Anthony S Basile; Steven W Barger
Journal:  J Neuroinflammation       Date:  2004-04-20       Impact factor: 8.322

6.  Serum Amino Acid Profiles in Normal Subjects and in Patients with or at Risk of Alzheimer Dementia.

Authors:  Gaetano Corso; Adriana Cristofano; Nadia Sapere; Giancarlo la Marca; Antonella Angiolillo; Michela Vitale; Roberto Fratangelo; Teresa Lombardi; Carola Porcile; Mariano Intrieri; Alfonso Di Costanzo
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2017-05-04

7.  Amino Acids in Cerebrospinal Fluid of Patients with Aneurysmal Subarachnoid Haemorrhage: An Observational Study.

Authors:  Bartosz Sokół; Bartosz Urbaniak; Norbert Wąsik; Szymon Plewa; Agnieszka Klupczyńska; Roman Jankowski; Barbara Więckowska; Robert Juszkat; Zenon Kokot
Journal:  Front Neurol       Date:  2017-08-28       Impact factor: 4.003

8.  Choroid plexus LAT2 and SNAT3 as partners in CSF amino acid homeostasis maintenance.

Authors:  Elena Dolgodilina; Simone M Camargo; Eva Roth; Brigitte Herzog; Virginia Nunes; Manuel Palacín; Francois Verrey
Journal:  Fluids Barriers CNS       Date:  2020-02-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.